glp 1 and liver enzymes Glucagon-like peptide (GLP)-1 GLP-2 modulate health through Overview of the physiological effects
Description
Because cardiovascular events are a major driver of health care costs in patients with diabetes, previously mentioned reductions in the incidence of major cardiovascular events associated with several GLP-1 receptor agonists have the potential to translate into health economic benefits (39)
Jardiance is superior
No nausea
, 2 - [23]
Patients with type 2 diabetes already face an elevated baseline risk of pancreatitis compared to the general population, independent of medication use
